Table 3.
Treatment1 | Control group | CP-challenged model group | Antibiotics (positive control group) |
B. subtilis PB6 low-dosage group | B. subtilis PB6 high-dosage group | SEM2 | P value3 |
---|---|---|---|---|---|---|---|
d1-d18 nonchallenge phase | |||||||
BWG (g) | 36.06 | 35.47 | 35.44 | 35.14 | 35.58 | 0.25 | 0.86 |
FI (g) | 51.61 | 50.87 | 51.65 | 51.79 | 51.97 | 0.44 | 0.95 |
FCR | 1.43 | 1.44 | 1.46 | 1.48 | 1.46 | 0.01 | 0.50 |
Mortality rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 |
d19-d26 challenge phase | |||||||
BWG (g) | 66.12a | 54.95c | 59.21bc | 61.62ab | 62.86ab | 1.087 | 0.009 |
FI (g) | 109.55a | 99.90bc | 98.35c | 106.30ab | 108.41a | 1.305 | 0.007 |
FCR | 1.66 | 1.83 | 1.67 | 1.73 | 1.73 | 0.02 | 0.062 |
Mortality rate (%) | 2.22 | 3.49 | 1.11 | 4.45 | 3.58 | 0.907 | 0.821 |
Overall | |||||||
BWG (g) | 46.47a | 42.21c | 43.67bc | 44.31abc | 45.02ab | 0.394 | 0.004 |
FI (g) | 71.66a | 67.84b | 67.81b | 70.66ab | 71.51a | 0.544 | 0.026 |
FCR | 1.55 | 1.61 | 1.55 | 1.6 | 1.59 | 0.009 | 0.151 |
Mortality rate (%) | 2.22 | 3.49 | 1.11 | 4.45 | 3.58 | 0.907 | 0.821 |
1Treatment information: control group: basal diet; CP-challenged model group: basal diet and CP challenge; antibiotics (positive control group): CP challenge+10 mg/kg enramycin; B. subtilis PB6 low-dosage group: CP challenge+4 × 107 CFU/kg of feed B. subtilis PB6; B. subtilis PB6 high-dosage group: CP challenge+6 × 107 CFU/kg of feed B. subtilis PB6. BWG: body weight gain; FI: feed intake; FCR: feed conversion ratio. 2Standard error of the means; n = 6 chickens/group. 3Mean values within a column with unlike superscripts letters (a, b, and c) are significantly different (P < 0.05).